Confidence intervals and statistical power of the ‘Validation’ ratio for surrogate or intermediate endpoints
- 1 June 2001
- journal article
- Published by Elsevier in Journal of Statistical Planning and Inference
- Vol. 96 (1) , 143-153
- https://doi.org/10.1016/s0378-3758(00)00330-x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKERStatistics in Medicine, 1997
- Perspective: Validating Surrogate Markers--Are We Being Naive?The Journal of Infectious Diseases, 1997
- Surrogate End Points in Clinical Trials: Are We Being Misled?Annals of Internal Medicine, 1996
- Sample Size for Studying Intermediate Endpoints within Intervention Trials or Observational StudiesAmerican Journal of Epidemiology, 1992
- Statistical validation of intermediate endpoints for chronic diseasesStatistics in Medicine, 1992
- Fieller's Theorem, the Likelihood and the Delta MethodBiometrics, 1990
- Surrogate endpoints in clinical trials: Definition and operational criteriaStatistics in Medicine, 1989
- Qualms About Bootstrap Confidence IntervalsJournal of the American Statistical Association, 1985